The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade

被引:72
作者
Bigenzahn, S
Blaha, P
Koporc, Z
Pree, I
Selzer, E
Bergmeister, H
Wrba, F
Heusser, C
Wagner, K
Muehlbacher, F
Wekerle, T [1 ]
机构
[1] Med Univ Vienna, Div Transplantat, Dept Surg, Vienna, Austria
[2] Med Univ Vienna, Dept Radiotherapy & Radiobiol, Vienna, Austria
[3] Med Univ Vienna, Biomed Res Inst, Vienna, Austria
[4] Med Univ Vienna, Inst Clin Pathol, Vienna Gen Hosp, Vienna, Austria
[5] Novartis Pharma Ag, Basel, Switzerland
关键词
costimulation; mixed chimerism; tolerance;
D O I
10.1111/j.1600-6143.2005.00862.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Peripheral and central clonal deletion are important tolerance mechanisms in models using bone marrow transplantation [BMT] with costimulation blockade (CB). However, since tolerance can be found before peripheral deletion is complete and since elimination of recipient CD4(+) cells at the time of BMT prevents tolerance induction, we investigated the potential roles of regulation and anergy in such a murine model. We found that transient elimination of CD25(+) cells or neutralization of IL2 immediately after BMT and CB prevented the induction of skin graft tolerance. Cotransfer into SCID mice of CD4(+) cells taken from chimeras early after BMT, together with naive recipient-type CD4(+) cells significantly prolonged donor skin graft survival. In contrast, cotransfer of CD4(+) cells harvested from chimeras late after BMT did not prolong donor skin graft survival. Besides, depletion of CD25(+) cells in established chimeras several months post-BMT did not break tolerance. In vivo administration of recombinant IL2 inhibited chimerism and tolerance neither early nor late post-BMT, arguing against a decisive role for classical anergy. Thus, CD4 cell-mediated regulation contributes significantly to tolerance induction early after BMT, but appears to have no critical role in the maintenance of tolerance.
引用
收藏
页码:1237 / 1247
页数:11
相关论文
共 55 条
[1]   Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression [J].
Adams, AB ;
Durham, MM ;
Kean, L ;
Shirasugi, N ;
Ha, JW ;
Williams, MA ;
Rees, PA ;
Cheung, MC ;
Mittelstaedt, S ;
Bingaman, AW ;
Archer, DR ;
Pearson, TC ;
Waller, EK ;
Larsen, CP .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :1103-1111
[2]   Conventional immunosuppression is compatible with costimulation blockade-based, mixed chimerism tolerance induction [J].
Adams, AB ;
Shirasugi, N ;
Jones, TR ;
Williams, MA ;
Durham, MM ;
Ha, JW ;
Dong, Y ;
Guo, Z ;
Newell, KA ;
Pearson, TC ;
Larsen, CP .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (07) :895-901
[3]   The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade [J].
Blaha, P ;
Bigenzahn, S ;
Koporc, Z ;
Schmid, M ;
Langer, F ;
Selzer, E ;
Bergmeister, H ;
Wrba, F ;
Kurtz, J ;
Kiss, C ;
Roth, E ;
Muehlbacher, F ;
Sykes, M ;
Wekerle, T .
BLOOD, 2003, 101 (07) :2886-2893
[4]   Variable hematopoietic graft rejection and graft-versus-host disease in MHC-matched strains of mice [J].
Cao, TM ;
Lo, B ;
Ranheim, EA ;
Grumet, FC ;
Shizuru, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11571-11576
[5]   Cutting edge: Administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning [J].
Durham, MM ;
Bingaman, AW ;
Adams, AB ;
Ha, JW ;
Waitze, SY ;
Pearson, TC ;
Larsen, CP .
JOURNAL OF IMMUNOLOGY, 2000, 165 (01) :1-4
[6]  
Filaci Gilberto, 2002, Autoimmunity Reviews, V1, P279, DOI 10.1016/S1568-9972(02)00065-4
[7]   Interleukin 2 signaling is required for CD4+ regulatory T cell function [J].
Furtado, GC ;
de Lafaille, MAC ;
Kutchukhidze, N ;
Lafaille, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :851-857
[8]   HUMAN T-CELL CLONAL ANERGY IS INDUCED BY ANTIGEN PRESENTATION IN THE ABSENCE OF B7 COSTIMULATION [J].
GIMMI, CD ;
FREEMAN, GJ ;
GRIBBEN, JG ;
GRAY, G ;
NADLER, LM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) :6586-6590
[9]   Both CD4+CD25+ and CD4+CD25- regulatory cells mediate dominant transplantation tolerance [J].
Graca, L ;
Thompson, S ;
Lin, CY ;
Adams, E ;
Cobbold, SP ;
Waldmann, H .
JOURNAL OF IMMUNOLOGY, 2002, 168 (11) :5558-5565
[10]   Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance [J].
Graca, L ;
Honey, K ;
Adams, E ;
Cobbold, SP ;
Waldmann, H .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :4783-4786